Codexis (CDXS) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

When Will Codexis, Inc. (NASDAQ:CDXS) Become Profitable?
Yahoo FinanceMar 1 09:06 ET
The Price Is Right For Codexis, Inc. (NASDAQ:CDXS) Even After Diving 32%
Simply Wall StMar 1 08:48 ET
Codexis Earnings Call: Growth Prospects and Challenges
TipRanksFeb 28 19:37 ET
Codexis Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results.
BenzingaFeb 28 14:48 ET
Stifel Maintains Codexis(CDXS.US) With Buy Rating, Maintains Target Price $5
Moomoo NewsFeb 28 09:31 ET · Ratings
Stifel Nicolaus Sticks to Their Buy Rating for Codexis (CDXS)
TipRanksFeb 28 08:48 ET · Ratings

Comments

Teddy123

Oct 10, 2024 21:41

financial results for the third quarter of 2024 on Thursday, October 31, 2024,

$Codexis (CDXS.US)$
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the third quarter of 2024 on Thursday, October 31, 2024, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm E...

Teddy123

Oct 7, 2024 07:27

Codexis secures $31 million to extend cash runwayInvesting.comPublished 10/02/2024, 04:16 PM

$Codexis (CDXS.US)$
Codexis is on the verge of launching an innovative platform for the efficient production of siRNA therapeutics, known as the ECO Synthesis™ Manufacturing Platform. The company has presented promising data that suggests this platform could overcome the scalability and cost limitations of traditional phosphoramidite chemistry used in oligonucleotide synthesis.
investing.com/n...

Teddy123

Oct 3, 2024 06:41

Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company

$Codexis (CDXS.US)$
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company | CDXS Stock News

Jaguar8

Oct 1, 2024 06:06

NEWS

$Codexis (CDXS.US)$
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
Codexis, Inc. (NASDAQ: CDXS) has entered into a non-exclusive commercial and manufacturing license agreement with Alphazyme , part of Maravai LifeSciences, for multiple enzymes in Codexis' life science enzyme portfolio. The agreement includes licenses for HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and dia...

1

Teddy123

Sep 30, 2024 00:17

Wall Street SWOT: Codexis stock pivots to RNAi, analysts see enzyme potentialInvesting.comPublished 09/27/2024, 10:47 AM

$Codexis (CDXS.US)$
Wall Street SWOT: Codexis stock pivots to RNAi, analysts see enzyme potential By Investing.com

CDXS Codexis

Trade Overview

Capital Trend

News

Comments

Trending Stocks